Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma

ID
Name
Soh-Med-22-09-14
Description
Colorectal carcinoma is a major health problem. As a malignant tumor, the malignant potential of colorectal carcinoma is based mainly on its ability to metastasis to different sites. Fascin-1 is an actin binding protein which is involved in reconstruction of intracellular actin network, the latter enforces the neoplastic cell to invade surrounding structures.
Trial arms
Trial start
2022-01-01
Estimated PCD
2022-09-30
Trial end
2022-12-01
Status
Completed
Treatment
Immunohistochemistry
immunohistochemical staining of colorectal carcinoma specimens by anti human fascin antibody.
Size
60
Primary endpoint
Evaluation of immunohistochemical staining of colorectal carcinoma by Fascin-1
September , 2022
Eligibility criteria
Inclusion Criteria: * All cases of colorectal carcinoma. Exclusion Criteria: * cases diagnosed on basis of lower endoscopic biopsies or local resections without radical colectomy. * Patients with preopoerative history of chemo or radiotherapy. * Patients with poor clinical data.
Protocol
{'studyType': 'OBSERVATIONAL', 'patientRegistry': False, 'designInfo': {'observationalModel': 'CASE_ONLY', 'timePerspective': 'PROSPECTIVE'}, 'enrollmentInfo': {'count': 60, 'type': 'ACTUAL'}}
Updated at
2023-04-12

1 organization

1 product

1 indication

Organization
Sohag University
Product
Immunohistochemistry
Indication
Colorectal Cancer